Brokerages Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PT at $86.67

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been assigned a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $86.67.

Several brokerages recently commented on ACHC. KeyCorp started coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Deutsche Bank Aktiengesellschaft increased their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Barclays reduced their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research note on Friday, September 20th.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the business. Blue Trust Inc. grew its stake in shares of Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the last quarter. Mather Group LLC. bought a new stake in shares of Acadia Healthcare during the first quarter valued at approximately $48,000. GAMMA Investing LLC raised its stake in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare in the second quarter worth $59,000. Finally, nVerses Capital LLC acquired a new stake in Acadia Healthcare during the second quarter worth $95,000.

Acadia Healthcare Stock Down 12.3 %

ACHC stock opened at $52.03 on Friday. The company has a 50 day moving average of $70.74 and a two-hundred day moving average of $69.51. The company has a market cap of $4.83 billion, a price-to-earnings ratio of -371.64, a PEG ratio of 1.57 and a beta of 1.29. Acadia Healthcare has a 12-month low of $51.07 and a 12-month high of $87.77. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. During the same quarter last year, the firm earned $0.92 earnings per share. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, equities analysts anticipate that Acadia Healthcare will post 3.51 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.